RDT&E Project · President's Budget PB2027

Emerging Threats (ATD)

FY2027 Request
$11.0M
▲ 22% vs FY2026
HitchAI read

Project ET3 — Emerging Threats (ATD) requests $11.0M in FY2027, 3.5% of the $310.3M requested for program element 0603384BP, up 22% on FY2026. 1 R-2A activity decomposes the request.

FY2027 Request
$11.0M
▲ 22% vs FY2026
FY2026 Enacted
$9.0M
▼ 28% vs FY2025
FY2025 Actual
$12.5M
Prior year
Project detail

What project ET3 buys

Project ET3 aims to identify and develop scientific solutions, or to modernize capabilities, that allow for a more rapid response to emerging threats. This project supports the development of defense capabilities, collaborating across the Department of War (DoW) and specific interagency partners for doctrine, equipment, and training for the warfighter and civilian population for defense against emerging threats. Additionally, this project supports advanced development of defensive science and technology capabilities aimed at proactive characterization of threats and potentially disruptive technologies.

Funding trajectory

Project ET3 funding, FY2025–FY2031

Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.

012.5FY25ACTUAL9.0FY26ENACTED11.0FY27REQUEST11.0FY2811.0FY2911.0FY3011.0FY31
Actual Enacted Request Outyear (FYDP)
Fiscal YearEstimate TypeAmount ($M)
FY2025Actual12.5
FY2026Enacted9.0
FY2027Request11.0
FY2028Outyear11.0
FY2029Outyear11.0
FY2030Outyear11.0
FY2031Outyear11.0
Inside the project

1 accomplishment / planned program

The R-2A exhibit — the only level of the budget that describes work that has not happened yet. Activities carry the prior, current and budget year only, no five-year plan. Each describes FY2027 work in enough detail to have its own page; the rest are shown here in full. Coverage is partial across the corpus, so count activities, never total them.

FY2025 actual$12.5M
FY2026 enacted$9.0M
FY2027 request$11.0M

Continue enhanced capability to more rapidly characterize and develop medical countermeasures against, emerging chemical and biological threats through investment in high throughput technologies. Continue development of challenges advancing concept and technology development.

Read the FY2027 plan →